GSK · 10000+ people · Public
Vice President - Oncology Clinical Development, Disease Area Head- Hematology
- London
- Hybrid · 2–3 days in office
- Director · manages people
Leads end-to-end clinical development strategy for a hematology oncology portfolio, from first-in-human studies through registrational trials, regulatory approval and initial launch. Provides program oversight at governance forums, co-leads asset development with matrix partners, and line-manages Clinical Development Leads, Medical Directors and Clinical Scientists. Champions novel approaches such as AI/ML, innovative trial designs and real-world data.
AI/ML